Evaluation of a method for identification of Candida dubliniensis bloodstream isolates.
Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients.
Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans.
The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.
Candida dubliniensis fungemia: the first four cases in North America.
Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation.
Widespread geographic distribution of oral Candida dubliniensis
strains in human immunodeficiency virus-infected individuals.
PCR fingerprinting: a convenient molecular tool to distinguish between Candida dubliniensis
and Candida albicans.
Candida species, including the novel opportunistic pathogen Candida dubliniensis
, are now emerging as major agents of nosocomial infections.
1) describing the first case of Candida dubliniensis
fungemia in Australia.
2) describing the first reported cases of Candida dubliniensis
fungemia from Europe and North America, respectively.
Candidiasis: the emergence of a novel species, Candida dubliniensis
The recently described species Candida dubliniensis
has been recovered primarily from superficial oral candidiasis in HIV-infected patients.